Role of BRD4 and its target Ptp1b in Endothelial cells and in cardiovascular disease models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Göttingen, Georg-August Universität, Dissertation, 2019
- Schlagwort
-
Endothelial cells
- Ereignis
-
Veröffentlichung
- (wo)
-
Göttingen
- (wer)
-
Niedersächsische Staats- und Universitätsbibliothek Göttingen
- (wann)
-
2019
- Urheber
- Beteiligte Personen und Organisationen
-
Pantakani, Dasaradha Venkata Krishna
Adham, Ibrahim
Hoyer-Fender, Sigrid
- Handle
-
11858/00-1735-0000-002E-E5D3-1
- URN
-
urn:nbn:de:gbv:7-11858/00-1735-0000-002E-E5D3-1-4
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 08:50 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shahid, Sidra
- Pantakani, Dasaradha Venkata Krishna
- Adham, Ibrahim
- Hoyer-Fender, Sigrid
- Niedersächsische Staats- und Universitätsbibliothek Göttingen
Entstanden
- 2019
Ähnliche Objekte (12)
BRD4: an effective target for organ fibrosis
Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
Endothelial vasoactive substances and cardiovascular disease
Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
Cdk9 and Brd4 regulate eukaryotic transcription
Influence of shear stress, inflammation and BRD4 inhibition on human endothelial cells: a holistic proteomic approach
BRD4 and Cancer: going beyond transcriptional regulation
High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription
Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
BRD4-mediated repression of p53 is a target for combination therapy in AML
Functional characterization of BRD4 in transcription elongation and termination
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
BRD4: an effective target for organ fibrosis
Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
Endothelial vasoactive substances and cardiovascular disease
Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
Cdk9 and Brd4 regulate eukaryotic transcription
Influence of shear stress, inflammation and BRD4 inhibition on human endothelial cells: a holistic proteomic approach
BRD4 and Cancer: going beyond transcriptional regulation
High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription
Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
BRD4-mediated repression of p53 is a target for combination therapy in AML
Functional characterization of BRD4 in transcription elongation and termination
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
BRD4: an effective target for organ fibrosis
Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets
Endothelial vasoactive substances and cardiovascular disease
Methylation of BRD4 by PRMT1 regulates BRD4 phosphorylation and promotes ovarian cancer invasion
Cdk9 and Brd4 regulate eukaryotic transcription
Influence of shear stress, inflammation and BRD4 inhibition on human endothelial cells: a holistic proteomic approach
BRD4 and Cancer: going beyond transcriptional regulation
High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription
Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexes
BRD4-mediated repression of p53 is a target for combination therapy in AML
Functional characterization of BRD4 in transcription elongation and termination